Skip to main content

Research

The latest research in type 1 diabetes, type 2 diabetes, prediabetes, and beyond. Here you’ll find information on experimental therapies, new data and results, and scientific findings.

Insulin pens and pumps are two of the most popular choices for insulin delivery. The CeQur Simplicity aims to combine the strengths of both of these technologies.
Vertex Pharmaceuticals announced its intention to acquire the biotechnology company ViaCyte for $320 million in cash, merging two leaders in beta cell replacement...
Researchers are dedicated to developing new mealtime insulins that can help improve glucose management and prevent highs and lows. Exciting new concentrated, ultra-rapid...
See if you are eligible to participate in this study looking at whether the One Touch Solutions platform and its associated partner programs can help people better...
A study looked at diabetes-related hospitalizations in France before and after people started using a FreeStyle Libre continuous glucose monitor (CGM). Results showed...
What is the risk of passing diabetes on to your children? Research shows that diabetes has a genetic component, but what does that mean?
Explore the unique challenges faced by transgender individuals managing diabetes, from health inequities to hormone therapy effects. Discover personal stories, advice,...
Mental health conditions, self-harm behaviors, and suicide are all too common in the diabetes community. Learn what the statistics mean; be sure to share these suicide...
Insulin has come a long way since its discovery over 100 years ago. Learn what new insulin options may be on the horizon that could revolutionize the way diabetes is...
If done safely, every person with diabetes can benefit from exercise, but there are unique advantages for women. Unfortunately, women with diabetes face barriers to...
Though certain sexual disorders are well-understood in men with diabetes, we know a lot less about the prevalence, impact, and management of sexual dysfunction in women...
A team of world-renowned experts in diabetes presented updates about automated insulin delivery (AID), focusing on the role of diet and exercise for closed-loop systems.
The iLet Bionic Pancreas is currently the closest automated insulin delivery system to a fully closed loop system. At ADA's 82nd Scientific Sessions, a panel of experts...
The American Diabetes Association's 82nd Scientific Sessions brought together great minds in diabetes for exciting news and discussions. Check out highlights from the...
Mounjaro (tirzepatide), a first-of-its kind medication for treating type 2 diabetes, has been approved by the FDA after much anticipation. This new medication has been...
Learn what some of the latest research says about the heart health benefits of diabetes drugs like SGLT-2 inhibitors, GLP-1 receptor agonists, and non-steroidal MRAs.
At ATTD 2022, researchers discussed the latest research on pregnancy, menstrual cycles, and overall health outcomes in women with diabetes. Diabetes technology can be a...
Automated insulin delivery systems are becoming more advanced and over time have become more widely adopted within the diabetes community. At ATTD 2022, experts...
In April 2022, 32 of the world’s premier diabetes experts gathered in Barcelona, along with representatives from industry, advocacy, and regulatory bodies, to discuss...
​For the first time, Time in Range was used as the main outcome measured in a clinical trial for a diabetes medication. Read about the study results and implications.

Pages